FR2321899B1 - - Google Patents

Info

Publication number
FR2321899B1
FR2321899B1 FR7624951A FR7624951A FR2321899B1 FR 2321899 B1 FR2321899 B1 FR 2321899B1 FR 7624951 A FR7624951 A FR 7624951A FR 7624951 A FR7624951 A FR 7624951A FR 2321899 B1 FR2321899 B1 FR 2321899B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7624951A
Other languages
French (fr)
Other versions
FR2321899A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIT RECH IND THERAPEUT
Original Assignee
RIT RECH IND THERAPEUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE159475A external-priority patent/BE832758A/fr
Application filed by RIT RECH IND THERAPEUT filed Critical RIT RECH IND THERAPEUT
Publication of FR2321899A1 publication Critical patent/FR2321899A1/fr
Application granted granted Critical
Publication of FR2321899B1 publication Critical patent/FR2321899B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/36011Togaviridae
    • C12N2770/36211Rubivirus, e.g. rubella virus
    • C12N2770/36234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7624951A 1975-08-26 1976-08-17 Vaccins bivalents contre la rubeole et la cytomegalie Granted FR2321899A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE159475A BE832758A (fr) 1975-08-26 1975-08-26 Vaccins bivalents contre la rubeole et la cytomegalie

Publications (2)

Publication Number Publication Date
FR2321899A1 FR2321899A1 (fr) 1977-03-25
FR2321899B1 true FR2321899B1 (enExample) 1978-12-22

Family

ID=3842805

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7624951A Granted FR2321899A1 (fr) 1975-08-26 1976-08-17 Vaccins bivalents contre la rubeole et la cytomegalie

Country Status (1)

Country Link
FR (1) FR2321899A1 (enExample)

Also Published As

Publication number Publication date
FR2321899A1 (fr) 1977-03-25

Similar Documents

Publication Publication Date Title
JPS5420155Y2 (enExample)
JPS5632983Y2 (enExample)
JPS5554914Y2 (enExample)
JPS5219986U (enExample)
JPS51150493U (enExample)
JPS51163491U (enExample)
JPS51126345U (enExample)
JPS5263619U (enExample)
BG22925A1 (enExample)
CH600349A5 (enExample)
CH603493A5 (enExample)
CH596119A5 (enExample)
CH597750A5 (enExample)
CH601869A5 (enExample)
CH594217A5 (enExample)
CH593638A5 (enExample)
CH594203A5 (enExample)
CH595212A5 (enExample)
CH593593A5 (enExample)
CH596265A5 (enExample)
BG22215A1 (enExample)
CH592186A5 (enExample)
CH595195A5 (enExample)
CH595243A5 (enExample)
BG22737A1 (enExample)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse